Exploring the Group B Streptococcus capsular polysaccharides: The structural diversity provides the basis for development of NMR-based identity assays

Journal of Pharmaceutical and Biomedical Analysis

Volumn 98, Issue , 2014, Pages 9-15

  Pinto, Vittoria ^a   Berti, Francesco ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Bacterial diseases; Capsular polysaccharide; Group B streptococcus; Nuclear magnetic resonance spectroscopy; Vaccine

Indexed keywords

BACTERIAL POLYSACCHARIDE; DISACCHARIDE; PNEUMOCOCCUS POLYSACCHARIDE; TRIPLE VACCINE; TRISACCHARIDE; BACTERIAL VACCINE;

ARTICLE; CONFORMATION; FOURIER TRANSFORMATION; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEROTYPE; SIGNAL TRANSDUCTION; STREPTOCOCCUS AGALACTIAE; ANIMAL; BACTERIAL CAPSULE; BIOASSAY; CHEMISTRY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; STREPTOCOCCUS;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL VACCINES; BIOLOGICAL ASSAY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS;

EID: 84901435265     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.05.004     Document Type: Article

References (20)

1. Heath P.T. An update on vaccination against group B streptococcus. Expert Rev. Vaccine 2011, 10:685-694.
2. Afshar B., Broughton K., Creti R., Decheva A., Hufnagel M., Kriz P., Lambertsen L., Lovgren M., Melin P., Orefici G., Poyart C., Radtke A., Rodriguez-Granger J., Sørensen U.B., Telford J., Valinsky L., Zachariadou L., Efstratiou A. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci). J. Clin. Microbiol. 2011, 49:1475-1482. Members of the DEVANI Study Group.
3. Yao K., Poulsen K., Maione D., Rinaudo C.D., Baldassarri L., Telford J., Sørensen U.B., Kilian M. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J. Clin. Microbiol. 2013, 51:503-507. U.B. Members of the DEVANI Study Group.
4. Jennings H.J., Katzenellenbogen E., Lugowski C., Kasper D.L. Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry 1983, 22:1258-1264.
5. Jennings H.J., Rosell K.-G., Katzenellenbogen E., Kasper D.L. Structural determination of the capsular polysaccharide antigen of type II group B streptococci. J. Biol. Chem. 1983, 258:1793-1798.
6. Jennings H.J., Lugowski C., Kasper D.L. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry 1981, 20:4511-4518.
7. Di Fabio J.L., Michon F., Brisson J.-R., Jennings H.J. Structure of the capsular polysaccharide antigen of type IV group B Streptococcus. Can. J. Chem. 1989, 67:877-882.
8. Wessels M.R., DiFabio J.L., Benedi V.-J., Kasper D.L., Michon F., Brisson J.-R., Jelinkova J., Jennings H.J. Structural determination and immunochemical characterization of the type V group B Streptococcus agalactiae capsular polysaccharide. J. Biol. Chem. 1991, 266:6714-6719.
9. von Hunolstein C., D'Ascenzi S., Wagner B., Jelinkova J., Alfarone G., Recchia S., Waner M., Orefici G. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B Streptococcus). Infect. Immun. 1993, 61:1272-1280.
10. Kogan G., Brisson J.-R., Kasper D.L., von Hunolstein C., Orefici G., Jennings G.H.J. Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr. Res. 1995, 277:1-9.
11. Kogan G., Uhrín D., Brisson J.-R., Paoletti L.C., Blodgett A.E., Kasper D.L., Jennings H.J. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J. Biol. Chem. 1996, 271:8786-8790.
12. Cieslewicz M.J., Chaffin D., Glusman G., Kasper D., Madan A., Rodrigues S., Fahey J., Wessels M.R., Rubens C.E. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect. Immun. 2005, 73:3096-3103.
13. Lin F.Y., Weisman L.E., Azimi P.H., Philips J.B., Clark P., Regan J., Rhoads G.G., Frasch C.E., Gray B.M., Troendle J., Brenner R.A., Moyer P., Clemens J.D. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J. Infect. Dis. 2004, 190:928-934.
14. Rappuoli R., Black S. Introduction addressing the challenge of group B streptococcal disease. Vaccine 2013, 31(Suppl. 4):D1-D2.
15. Jones C. NMR assays for carbohydrate-based vaccines. J. Pharm. Biomed. Anal. 2005, 38:840-850.
16. Bardotti A., Averani G., Berti F., Berti S., Carinci V., D'Ascenzi S., Fabbri B., Giannini S., Giannozzi A., Magagnoli C., Proietti D., Norelli F., Rappuoli R., Ricci S., Costantino P. Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases. Vaccine 2008, 26:2284-2296.
17. Abeygunawardana C., Williams T.C., Sumner J.S., Hennessey J.P. Development and validation of an NMR-based identity assay for bacterial polysaccharides. Anal. Biochem. 2000, 279:226-240.
18. Wessels M.R., Paoletti L.C., Kasper D.L., DiFabio J.L., Michon F., Holme K., Jennings H.J. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 1990, 86:1428-1433.
19. Cieslewicz M.J., Kasper D.L., Wang Y., Wessels M.R. Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J. Biol. Chem. 2001, 276:139-146.
20. Wang Y., Hollingsworth R.I., Kasper D.L. Ozonolysis for selectively depolymerizing polysaccharides containing beta-d-aldosidic linkages. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6584-6589.